Y-Intercept (HK)’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.18M Sell
179,426
-151,704
-46% -$2.56M 0.07% 408
2026
Q2
$5.26M Sell
331,130
-194,733
-37% -$3.02M 0.1% 264
2026
Q1
$7.1M Buy
525,863
+353,591
+205% +$4.95M 0.13% 205
2025
Q4
$2.14M Sell
172,272
-182,092
-51% -$1.96M 0.05% 593
2025
Q3
$3.51M Buy
354,364
+302,355
+581% +$2.94M 0.08% 338
2025
Q2
$464K Sell
52,009
-21,282
-29% -$180K 0.01% 1231
2025
Q1
$638K Buy
73,291
+42,886
+141% +$450K 0.04% 597
2024
Q4
$379K Buy
30,405
+17,547
+136% +$216K 0.03% 849
2024
Q3
$149K Buy
+12,858
New +$148K 0.01% 1195
2024
Q2
– Sell
-152,924
Closed -$1.83M – 1971
2024
Q1
$1.83M Sell
152,924
-8,327
-5% -$100K 0.14% 187
2023
Q4
$1.75M Buy
+161,251
New +$1.54M 0.16% 161
2023
Q1
– Sell
-103,397
Closed -$1.15M – 1573
2022
Q4
$1.15M Buy
+103,397
New +$1.08M 0.17% 165
2022
Q1
– Sell
-67,011
Closed -$907K – 983
2021
Q4
$907K Buy
+67,011
New +$895K 0.22% 132

Other funds holding VTRS

Y-Intercept (HK)'s VTRS Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Viatris (VTRS) stake by 46% in Q3 2026, selling an estimated $2.56M and leaving 179,426 shares worth $3.18M. The position accounts for 0.07% of the portfolio, ranked #408.

Y-Intercept (HK) first reported a position in VTRS in Q4 2021 and has held it in 13 quarters since. The position peaked at $7.1M in Q1 2026. 229 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • Y-Intercept (HK) held 179,426 shares of Viatris worth $3.18M as of Q3 2026.
  • Y-Intercept (HK) sold 151,704 Viatris shares in Q3 2026, an estimated $2.56M.
  • Viatris made up 0.07% of Y-Intercept (HK)'s portfolio in Q3 2026, its #408 holding.
  • Y-Intercept (HK) first reported a position in Viatris in Q4 2021 and has held it in 13 quarters since.
  • Y-Intercept (HK)'s Viatris position peaked at $7.1M in Q1 2026.
  • 229 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.